Medical devices, healthcare technology and the business of care
510(k) clearance · K262538

Artix MT;Artix Thin-Walled Sheath

Inari Medical, Inc. · Decision date Aug 21, 2026

FDA DECISIONK262538

What did the FDA decide?

FDA records K262538 as a 510(k) premarket notification, with a decision dated Aug 21, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Aug 21, 2026

FDA source record

Regulatory record facts

Identifier
K262538
Regulatory pathway
510(k) premarket notification
Product code
QEW
Decision code
SESE
Decision date
Aug 21, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Peripheral Mechanical Thrombectomy With Aspiration.

Product code
QEW
FDA device class
2

FDA decision timeline

  1. K262538 received

    Application receipt date recorded by FDA.

  2. K262538 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code QEW

Product / regulatory recordCompanyPathwayDecision dateSource
Penumbra Inc.510(k) clearanceOct 15, 2026FDA
Inari Medical, Inc.510(k) clearanceSep 18, 2026FDA
Endovascular Engineering510(k) clearanceSep 3, 2026FDA
Jupiter Endovascular510(k) clearanceAug 4, 2026FDA
Penumbra Inc.510(k) clearanceApr 24, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Inari Medical, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Irvine, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records